Date | Time | Source | Headline | Symbol | Company |
08/26/2024 | 2:03PM | iHub Newswire | FeaturedELEMENT79 ANNOUNCES UPLISTING TO OTCQB VENTURE MARKET | | |
08/13/2024 | 4:01PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
08/09/2024 | 5:06PM | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
08/08/2024 | 4:30PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
08/02/2024 | 10:42AM | Edgar (US Regulatory) | Form 8-K - Current report | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
07/30/2024 | 7:49PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
06/17/2024 | 12:40PM | AllPennyStocks.com | Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
06/04/2024 | 5:11PM | Edgar (US Regulatory) | Form 8-K - Current report | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
06/03/2024 | 5:22PM | Edgar (US Regulatory) | Form DEF 14A - Other definitive proxy statements | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
05/22/2024 | 4:13PM | Edgar (US Regulatory) | Form PRE 14A - Other preliminary proxy statements | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
05/10/2024 | 5:04PM | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
03/01/2024 | 5:04PM | Edgar (US Regulatory) | Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
12/01/2023 | 8:31PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
12/01/2023 | 8:31PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
11/16/2023 | 5:11PM | Edgar (US Regulatory) | Form 8-K - Current report | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
11/15/2023 | 7:19AM | InvestorsHub NewsWire | Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
11/09/2023 | 4:30PM | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
11/09/2023 | 8:00AM | InvestorsHub NewsWire | Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
11/07/2023 | 7:29AM | InvestorsHub NewsWire | Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
08/09/2023 | 4:36PM | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
04/05/2023 | 7:32PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
04/05/2023 | 9:31AM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
03/13/2023 | 7:35AM | InvestorsHub NewsWire | Nightfood, Inc. (OTCQB: NGTF) now in Sonesta International Hotels Multiple Brands | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
02/28/2023 | 4:31PM | Edgar (US Regulatory) | Annual Report (10-k) | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
02/07/2023 | 5:55PM | Edgar (US Regulatory) | Annual Statement of Changes in Beneficial Ownership (5) | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
01/13/2023 | 4:34PM | Edgar (US Regulatory) | Current Report Filing (8-k) | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
01/06/2023 | 4:42PM | Edgar (US Regulatory) | Current Report Filing (8-k) | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
12/23/2022 | 5:24PM | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
12/16/2022 | 1:40PM | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
12/05/2022 | 7:01AM | Edgar (US Regulatory) | Proxy Statement (definitive) (def 14a) | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |